News

Latest news

1st December 2020

Sequana Medical announces positive interim data from North American pivotal alfapump® study (POSEIDON)

Read more
16th November 2020

Sequana Medical announces strong interim results from RED DESERT alfapump® DSR study and provides business update

Read more
2nd October 2020

Acticor Biotech Announces the Success of the First Phase of its ACTIMIS Study with Glenzocimab in Patients with Acute Ischemic Stroke

Read more
30th July 2020

ジェイファーマ株式会社 総額 17 億 4 千 6 百万円の資金調達完了

Read more
30th July 2020

J-Pharma Raises 1,746 million JPY in Funding

Read more
23rd January 2020

Sequana Medical Successfully Raises EUR 19 million in an Equity Placement

Read more
7th January 2020

Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients

Read more
19th September 2019

Sequana Medical appoints leading experts as Heart Failure Scientific Advisors

Read more
4th June 2019

Sequana Medical announces unconditional IDE approval from U.S. FDA to start alfapump® pivotal study (POSEIDON)

Read more